Interstitial Lung Disease Induced by Drugs and Radiation

  title={Interstitial Lung Disease Induced by Drugs and Radiation},
  author={Philippe Camus and Annlyse Fanton and Philippe Bonniaud and Clio Camus and Pascal Foucher},
  pages={301 - 326}
An ever-increasing number of drugs can reproduce variegated patterns of naturally occurring interstitial lung disease (ILD), including most forms of interstitial pneumonias, alveolar involvement and, rarely, vasculitis. Drugs in one therapeutic class may collectively produce the same pattern of involvement. A few drugs can produce more than one pattern of ILD. The diagnosis of drug-induced ILD (DI-ILD) essentially rests on the temporal association between exposure to the drug and the… 

Figures and Tables from this paper

Drug Induced Interstitial Lung Disease

There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease.

Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics

A tight control (pulmonary function tests and/or HRCT) is mandatory in patients with preexisting ILD, but it should be also performed in those presenting risk factors for ILD and mild respiratory symptoms.

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches

  • O. Matsuno
  • Medicine, Biology
    Respiratory Research
  • 2012
Using peripheral blood samples from drug-allergic patients, the drug-induced lymphocyte stimulation test (DLST) and the leukocyte migration test (LMT) can detect the presence of drug-sensitized T cells, however, these tests do not have a definite role in the diagnosis of DILD.

Does drug-induced emphysema exist?

The question whether drugs do not cause toxicities that result in alveolar–capillary cell changes and emphysematous lung parenchyma destruction in humans, or whether drug-inducedEmphysema is simply not reported is asked.

Interstitial Lung Disease

The diagnostic pathway is being continually refined, with updates in disease classification, introduction of novel tools such as transbronchial cryobiopsy, and a move toward molecular-driven diagnostic approaches.

Pathology of DLI: What Is the Pathological Significance of DLI?

Lung biopsy is key if DI-ILD is suspected clinically and pathologists and clinicians must monitor patients for emerging forms of drug toxicity through clinico-radiologic-pathological diagnostics.

Drug-induced lung diseases: A state-of-the-art review

Important components of the workup include chest radiography, pulmonary function testing, and bronchoscopy with bronchoalveolar lavage (BAL), which is particularly helpful in identifying eosinophilic pneumonia and diffuse alveolar hemorrhage and in ruling out infectious causes.

Interstitial lung diseases in children

Current concepts of pathophysiological mechanisms, etiology and diagnostic approaches, as well as therapeutic strategies are reviewed, to discuss the various causes of pediatric ILD specific to infancy.

Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease

  • T. Suda
  • Medicine
    Clinical medicine insights. Circulatory, respiratory and pulmonary medicine
  • 2015
The characteristics of RA-ILD are assessed by overviewing recent studies in the field and focused on the clinical significance of histological and/or radiological patterns inRA-ILD.



Drug-induced pneumonitis: the role of methotrexate.

An exhaustive review of the English literature and identified 189 cases of methotrexate-induced pneumonitis (MIP), with Rheumatoid arthritis was the most frequent underlying disease and the prognosis is usually favorable, but occasionally the outcome may be fatal.

Bronchoalveolar lavage in drug-induced lung disease.

Pulmonary drug toxicity: radiologic and pathologic manifestations.

Pulmonary drug toxicity is increasingly being diagnosed as a cause of acute and chronic lung disease and knowledge of these manifestations and of the drugs most frequently involved can facilitate diagnosis and institution of appropriate treatment.

Infiltrative lung disease due to noncytotoxic agents.

Pathologic characteristics of drug-induced lung disease.

Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.

It is important that all patients receiving methotrexate be educated concerning this potential adverse reaction and instructed to contact their physicians should significant new pulmonary symptoms develop while undergoing therapy, and if metotrexate pneumonitis is suspected, methotRexate should be discontinued.

Diagnostic Invasive Procedures in Diffuse Infiltrative Lung Diseases

In this article invasive diagnostic procedures in patients with diffuse lung infiltrates are discussed from the perspective of their clinical context and their imaging characteristics.

Methotrexate pulmonary toxicity.

  • G. Cannon
  • Medicine
    Rheumatic diseases clinics of North America
  • 1997

Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.

  • R. TomiokaT. King
  • Medicine
    American journal of respiratory and critical care medicine
  • 1997
Features that distinguish gold-induced pulmonary disease from rheumatoid lung disease include female predominance, presence of fever or skin rash, absence of subcutaneous nodules or finger clubbing, lymphocytosis in bronchoalveolar lavage fluid (BALF), and alveolar opacities along the bronchovascular bundles on chest CT scan.